Cobblestone Capital Advisors LLC Abbott Laboratories Transaction History

Cobblestone Capital Advisors LLC

$1.6 Billion
Q2 2024

A detailed history of Cobblestone Capital Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cobblestone Capital Advisors LLC holds 8,490 shares of ABT stock, worth $978,897. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,490

Previous 8,490 -0.0%

Holding current value

$978,897

Previous $964,000 8.51%

% of portfolio

0.06%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $65,712 - $72,576	600 Added 7.6%	8,490 $964,000
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $19,390 - $23,736	-215 Reduced 2.65%	7,890 $868,000
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $14,616 - $17,536	153 Added 1.92%	8,105 $784,000
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $49,684 - $55,358	-493 Reduced 5.84%	7,952 $866,000
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $504,834 - $594,220	-5,212 Reduced 38.16%	8,445 $855,000
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $6,464 - $7,583	68 Added 0.5%	13,657 $1.5 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $102,478 - $123,863	1,004 Added 7.98%	13,589 $1.48 Million
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $1,140 - $1,390	-10 Reduced 0.08%	12,585 $1.49 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $2,310 - $2,829	-20 Reduced 0.16%	12,595 $1.77 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $6,182 - $6,840	-53 Reduced 0.42%	12,615 $1.49 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $8,886 - $10,460	-84 Reduced 0.66%	12,668 $1.47 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $5,442 - $6,411	-50 Reduced 0.39%	12,752 $1.53 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $630 - $686	-6 Reduced 0.05%	12,802 $1.4 Million
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $5,956 - $7,233	-65 Reduced 0.5%	12,808 $1.39 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $3,522 - $4,508	-46 Reduced 0.36%	12,873 $1.18 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $48,622 - $71,099	-774 Reduced 5.65%	12,919 $1.02 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $85,261 - $94,916	-1,086 Reduced 7.35%	13,693 $1.19 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $115,148 - $124,857	-1,407 Reduced 8.69%	14,779 $1.24 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $91,901 - $107,185	-1,261 Reduced 7.23%	16,186 $1.36 Million
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $55,227 - $66,770	-834 Reduced 4.56%	17,447 $1.4 Million
Q4 2018 Jan 30, 2019	BUY	$65.56 - $74.27 $17,701 - $20,052	270 Added 1.5%	18,281 $1.32 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $21,283 - $25,676	-350 Reduced 1.91%	18,011 $0
Q2 2018 Aug 03, 2018	BUY	$57.57 - $63.54 $98,444 - $108,653	1,710 Added 10.27%	18,361 $0
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $70,506 - $79,715	-1,253 Reduced 7.0%	16,651 $998,000
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $23,619 - $25,286	-440 Reduced 2.4%	17,904 $1.02 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $881,612 - $983,972	18,344	18,344 $979,000

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cobblestone Capital Advisors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Cobblestone Capital Advisors LLC with notifications on news.

Account

Cobblestone Capital Advisors LLC Abbott Laboratories Transaction History